143 related articles for article (PubMed ID: 1580897)
1. New insights into the activity of third-generation cephalosporins against pneumonia-causing bacteria.
Jones RN; Erwin ME; Bale M
Diagn Microbiol Infect Dis; 1992 Jan; 15(1):73-80. PubMed ID: 1580897
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.
Jones RN; Pfaller MA; Allen SD; Gerlach EH; Fuchs PC; Aldridge KE
Diagn Microbiol Infect Dis; 1991; 14(4):361-4. PubMed ID: 1889187
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Higashi Y; Kamimura T; Matsumoto Y; Tawara S; Matsumoto F
J Antibiot (Tokyo); 1993 Jan; 46(1):71-87. PubMed ID: 8436562
[TBL] [Abstract][Full Text] [Related]
4. Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.
Thornsberry C
Am J Med; 1985 Aug; 79(2A):14-20. PubMed ID: 3927723
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
Jones RN
Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
[TBL] [Abstract][Full Text] [Related]
6. Third-generation cephalosporins: comparative antibacterial activity against routine clinical isolates.
Corser CA; Day GJ; Humble MW
N Z Med J; 1982 Jun; 95(710):414-6. PubMed ID: 6810246
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologic basis for the use of third-generation cephalosporins.
Neu HC
Am J Med; 1990 Apr; 88(4A):3S-11S. PubMed ID: 2183607
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of third-generation cephalosporins.
Fass RJ
Arch Intern Med; 1983 Sep; 143(9):1743-5. PubMed ID: 6615095
[TBL] [Abstract][Full Text] [Related]
11. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
12. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Richards DM; Heel RC
Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
[TBL] [Abstract][Full Text] [Related]
13. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
14. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
Jones RN; Erwin ME
Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of blood isolates to various antibiotics, in particular to cephalosporins.
Ling J; Chau PY; Leung YK; Ng WS
J Antimicrob Chemother; 1983 May; 11(5):473-80. PubMed ID: 6874632
[TBL] [Abstract][Full Text] [Related]
17. Third-generation and investigational cephalosporins: I. Structure-activity relationships and pharmacokinetic review.
Garzone P; Lyon J; Yu VL
Drug Intell Clin Pharm; 1983; 17(7-8):507-15. PubMed ID: 6347596
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
19. Third generation cephalosporins.
Donowitz GR
Infect Dis Clin North Am; 1989 Sep; 3(3):595-612. PubMed ID: 2671141
[TBL] [Abstract][Full Text] [Related]
20. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
